Super Shred (L-Carnitine + MIC + ATP + Albuterol + B12 Compounded Blend)

📦 Każde zamówienie jest objęte naszą Reshipment Assurance Policy — jeśli Twoja przesyłka nie dotrze w ciągu 20 dni roboczych, wysyłamy ją ponownie.

Ingredient Breakdown — Per mL and Per 10 mL Vial

Each 10 mL Super Shred vial contains the following five active components dissolved in sterile aqueous vehicle. Per-component CAS, molecular formula, molecular weight, and amounts per mL / per vial are listed below for spec-sheet reference.

What Is the Super Shred Blend?

Super Shred is a research-grade compounded liquid blend that combines five complementary metabolic and adrenergic research compounds in a single pre-formulated sterile injectable solution. The blend is engineered to recruit several distinct mechanisms relevant to fat-oxidation, mitochondrial-function, and adrenergic-metabolic research in one administration: substrate-side support for mitochondrial fatty-acid transport (L-carnitine), hepatic lipid-export support (MIC lipotropic axis), cellular energy-currency support (ATP), β2-adrenergic-receptor agonism (albuterol), and one-carbon-cycle cofactor support (B12). Unlike the lyophilized peptide products in this catalogue, Super Shred is supplied as a ready-to-use sterile liquid at 553 mg/mL total active concentration — no reconstitution required.

Each of the five components has a distinct research profile, well-documented mechanism, and substantial published literature in its own right. The compounded blend format is offered because many research protocols that examine multi-axis metabolic intervention (substrate availability × electron-transport × adrenergic stimulation) require simultaneous administration of all five compounds at fixed ratios — making pre-formulated co-administration substantially more practical than reconstituting and combining each component separately for each dosing event.

Super Shred contains albuterol (salbutamol), a regulated β2-adrenergic agonist with established clinical use in respiratory medicine. Researchers ordering this product are responsible for compliance with the regulatory framework that applies in their jurisdiction. The blend is nie jest zatwierdzony by the FDA, EMA, MHRA, or any other major regulator as a compounded research formulation, and individual components have varying approval status (levocarnitine and cyanocobalamin are FDA-approved; albuterol is FDA-approved by inhalation and oral route but not as part of this blend; ATP and MIC components are not approved). The research-grade Super Shred sold here is supplied tylko do użytku laboratoryjnego and is not intended for human or veterinary administration.

Mechanism of Action — Five Complementary Pathways

The five components in Super Shred recruit complementary research-relevant mechanisms:

• L-Carnitine — Mitochondrial long-chain fatty-acid shuttle. Levocarnitine is the obligate carrier for long-chain fatty acids across the otherwise-impermeable mitochondrial inner membrane via the CPT-I / CACT / CPT-II transport system. At 400 mg/mL, the blend’s L-carnitine dose dominates total mass; the design rationale is to provide substrate-side substrate so that β-oxidation is not limited by carrier availability. See standalone L-Carnitine for full mechanistic detail.
• MIC Blend (Methionine, Inositol, Choline) — Hepatic lipid export and methyl-donor support. The classical “MIC lipotropic” mixture in research dosing supports hepatic phosphatidylcholine biosynthesis (via choline), one-carbon metabolism and S-adenosylmethionine pool (via methionine), and inositol-phospholipid signalling (via myo-inositol). Together these support the hepatic export of triglyceride-rich very-low-density lipoprotein (VLDL), which is the downstream limiting step for liver fat clearance. The 100 mg/mL combined dose places MIC in a moderate-supplementation range used in published research protocols on hepatic steatosis and fat-mobilisation models.
• ATP (Adenosine Triphosphate Disodium) — Cellular energy currency. Exogenous ATP has been studied in cardiovascular, ischemia-reperfusion, and exercise-physiology research contexts. While intracellular ATP is rapidly synthesised by mitochondria and cannot be directly imported from the extracellular space, extracellular ATP signals through purinergic receptors (P2X / P2Y families) and contributes to vasodilation, mast-cell modulation, and endothelial signalling. ATP also serves as a substrate reserve for circulating adenosine generation by ectonucleotidases (CD39 / CD73).
• Albuterol (Salbutamol) — β2-adrenergic receptor agonist. Albuterol is a short-acting selective β2-adrenergic receptor agonist. At the molecular level it activates Gαs-coupled β2-receptors on multiple tissues — including bronchial smooth muscle (the indication for which it is clinically approved), but also skeletal muscle (where it promotes glycogenolysis, lipolysis, and protein synthesis at supraphysiological doses), adipose tissue (lipolysis via cAMP / hormone-sensitive lipase), and the central nervous system (CNS-stimulant-like effects). Albuterol is on the WADA Prohibited List above defined urinary thresholds. Researchers handling albuterol must be aware of local regulatory status — albuterol is a prescription-only drug in most jurisdictions and is a controlled substance in some athletic-regulatory frameworks.
• Vitamin B12 (Cyanocobalamin) — One-carbon-cycle cofactor. B12 is an essential cofactor for methionine synthase and methylmalonyl-CoA mutase, supporting one-carbon metabolism, S-adenosylmethionine (SAM) synthesis, and odd-chain fatty-acid catabolism. B12 deficiency disrupts methylation reactions, neurological function, and erythropoiesis. In compounded lipotropic blends, B12 is included both as a one-carbon-cycle cofactor (synergistic with MIC) and as a visible quality-control marker — its red pigment provides a colour signal that the blend is intact.

The combined blend acts on substrate availability (L-carnitine), hepatic processing (MIC), cellular energy (ATP), adrenergic-receptor stimulation (albuterol), and methyl-cofactor support (B12) simultaneously. Research protocols that aim to dissect multi-axis interventions in fat-oxidation or metabolic-flexibility models use compounded co-administration of the full blend; researchers needing to dissect single-axis contributions instead use the standalone components separately (see L-Carnitine standalone, NAD⁺).

Opublikowane zastosowania badawcze

Super Shred is used in laboratory research contexts that investigate:

• Multi-axis fat-oxidation research — combined substrate-availability + adrenergic-stimulation + hepatic-export research in rodent and large-animal models
• Adrenergic-metabolic interaction research — β2-adrenergic stimulation of skeletal-muscle lipolysis in the presence of mitochondrial substrate (L-carnitine) and methyl-donor cofactors
• Exercise physiology and substrate utilisation — multi-component intervention studies on endurance performance, substrate switching, and post-exercise recovery in rodent and large-animal models (where local regulatory frameworks permit)
• Hepatic lipid-clearance research — the MIC component is the classical lipotropic research mixture for hepatic-steatosis and VLDL-export models
• Mitochondrial-bioenergetic research — combined substrate + cofactor intervention on mitochondrial function in cardiac, hepatic, and skeletal-muscle research
• Purinergic signalling research — the ATP component supports extracellular purinergic receptor research alongside the other metabolic compounds
• Compounded-blend formulation research — studies on the stability, pharmacokinetic interactions, and bioavailability of multi-ingredient liquid research blends

For broader context on related single-component mitochondrial / metabolic research compounds in this catalogue, see L-Carnitine standalone (mitochondrial fatty-acid shuttle), NAD⁺ (electron-transport coenzyme), SS-31 (Elamipretide) (cardiolipin-targeted mitochondrial peptide), and MOTS-c (mitochondrial-derived metabolic-regulator peptide). Browse the full katalog peptydów i związków badawczych w poszukiwaniu powiązanych związków.

Available Pack Sizes

MedsBase stocks Super Shred in three pack sizes calibrated to typical research-protocol durations. Each pack contains 10 mL vials of pre-formulated 553 mg/mL solution:

How It Compares — Super Shred vs Standalone L-Carnitine

Super Shred and standalone L-Carnitine share L-carnitine as a major component but differ substantially in formulation strategy, complexity, and use case. Standalone L-Carnitine is a single-axis research tool for substrate-side mitochondrial fat-oxidation studies. Super Shred is a multi-axis compounded blend designed for research protocols that require simultaneous substrate, adrenergic, and cofactor intervention.

For mechanistic single-component research where a clean attribution of effect to a specific mechanism matters, the standalone components are the appropriate tools. For applied multi-axis research where the entire blend is the intervention being studied, Super Shred is the appropriate research compound.

Przechowywanie i obchodzenie się

On receipt: Refrigerate at 2–8 °C immediately. The vial ships in temperature-controlled packaging — transfer to a dedicated refrigerator without delay. Nie zamrażać the liquid — freeze-thaw cycles cause vitamin B12 degradation, ATP hydrolysis, and potentially albuterol oxidation. Protect from direct light at all times (B12 is photosensitive). The clear pale-yellow colour reflects cyanocobalamin and is normal; deeper colour darkening or appearance of particulates indicates degradation — discard such vials.

Vial handling: Super Shred is supplied as a sterile multi-dose research vial. Use aseptic technique for each withdrawal: wipe the stopper with 70% isopropyl alcohol; use a fresh sterile needle and syringe per withdrawal. Do not over-pressurise the vial — air injection into a multi-dose vial is acceptable but should be modest. Swirl gently before each withdrawal to ensure uniform mixing of the five components. Once first-punctured, use within 60 days. Discard the vial if any cloudiness, particulates, colour deepening, or odour change appears.

Najczęściej zadawane pytania

Is Super Shred a peptide?

No. Super Shred is a multi-ingredient small-molecule research-injectable blend — not a peptide. We stock it in our research-peptide catalogue alongside NAD⁺ i L-Karnityna because it serves complementary mitochondrial / metabolic research applications and is supplied in the same injectable-vial format. The Spec Sequence row is marked “n/a” for this reason and the Ingredient Breakdown table replaces the single-CAS-row format used for individual peptides.

Why is the blend called “Super Shred”?

“Super Shred” is the supplier’s product designation reflecting the blend’s marketing positioning around fat-oxidation and metabolic research. The research framing used here is broader than the marketing name suggests — fat-oxidation is one application but multi-axis adrenergic and mitochondrial research are equally relevant uses. We retain the supplier name for cross-vendor traceability.

What does “MIC blend” mean and what are the three components?

MIC is the classical lipotropic research mixture: Methionine (an essential amino acid and methyl donor), Inositol (a carbocyclic polyol cofactor for second-messenger phosphoinositide signalling), and Choline (a precursor for phosphatidylcholine biosynthesis and the lipid neurotransmitter acetylcholine). Together these three compounds support hepatic phospholipid biosynthesis and lipoprotein export — historically the basis for the “lipotropic” research designation. The 100 mg/mL combined dose places MIC in a moderate-supplementation range used in published research protocols.

Why is albuterol included? Is this legal in my jurisdiction?

Albuterol (salbutamol) is a selective β2-adrenergic agonist included in this blend for its established research effects on adrenergic-receptor-mediated lipolysis and skeletal-muscle metabolism. Albuterol is a prescription-only drug in most jurisdictions and is on the WADA Prohibited List above defined urinary thresholds. Researchers handling this product are responsible for compliance with the regulatory framework in their jurisdiction. This product is supplied for laboratory research use only and not for human or veterinary administration.

What does “compounded blend” mean?

A compounded blend is a research formulation that combines multiple individual active ingredients into a single pre-mixed solution at fixed ratios. Unlike a single-component product (like our standalone L-Carnitine), a compounded blend cannot be cleanly attributed to a single mechanism — the observed effects are the sum of all components acting together. Compounded blends are preferred when the entire combination is the research intervention being studied; standalone components are preferred when single-mechanism attribution matters.

How is this different from reconstituting the lyophilized peptides?

The lyophilized peptide products in this catalogue ship as dry powder and require reconstitution with bacteriostatic water before use. Super Shred is supplied as a pre-formulated sterile liquid — ready to use, no reconstitution needed. This simplifies research-protocol setup but limits shelf life after first vial puncture compared to the dry-lyophilized format.

Can I freeze Super Shred to extend the shelf life?

No. The blend contains components that are damaged by freeze-thaw cycles — B12 (cyanocobalamin) is sensitive to freezing-induced photolytic damage, ATP can hydrolyse, and albuterol can oxidise. Store refrigerated at 2–8 °C and use within 60 days of first puncture. The dry lyophilized standalone components (L-Carnitine, NAD⁺) can be frozen for long-term storage — but the compounded liquid blend cannot.

What administration routes are used in published research?

Intramuscular and subcutaneous routes are the most common in published research on multi-ingredient lipotropic and adrenergic-metabolic blends. Intravenous administration is less common because of the higher volume per dose. Researchers should determine the appropriate route from peer-reviewed literature specific to their protocol — and note that the regulatory framework for albuterol administration may further constrain the available routes in some jurisdictions.

Companion Research Compounds

• L-Carnitine (Levocarnitine) — Standalone L-Carnitine vials for dose-titration research or alternative protocols
• Vitamin B12 (Cyanocobalamin) Injectable — Standalone B12 component for separate dosing
• 5-Amino-1MQ — NNMT inhibitor for NAD-axis / metabolic research
• AOD-9604 — HGH-fragment lipolytic peptide — orthogonal fat-loss mechanism
• AICAR (Acadesine) — AMPK activator — exercise-mimetic research
• BAC Water (Woda bakteriostatyczna) — Sterile 0.9% benzyl-alcohol diluent for any lyophilized companion vials

Więcej opcji w Peptydach

Ranking według liczby ostatnich zamówień MedsBase — co wybierają inni klienci w tej kategorii.

BPC-157

US$115.00 – US$705.00Fourchette de prix : US$115.00 à US$705.00

Retatrutide

US$310.00 – US$6,515.00Fourchette de prix : US$310.00 à US$6,515.00

BAC Water (Woda bakteriostatyczna)

US$50.00 – US$150.00Fourchette de prix : US$50.00 à US$150.00

NAD⁺

US$210.00 – US$1,975.00Fourchette de prix : US$210.00 à US$1,975.00